injectable glp 1 Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 V2 - Regenics

Novo Nordisk combined semaglutide with an absorption enhancer called SNAC (sodium N- [8-(2-hydroxybenzoyl)amino] caprylate) which facilitates absorption in the stomach by increasing local pH and cell membrane permeability

Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada

"Differentiation strategies in obesity therapeutics." [25] MedImmune

Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments

doi:10.1016/j.survophthal.2023.07.002 108